Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xeris Biopharma Holdings (XERS) Exchange Rate Effect: 2020-2021

Historic Exchange Rate Effect for Xeris Biopharma Holdings (XERS) over the last 2 years, with Dec 2021 value amounting to -$3,000.

  • Xeris Biopharma Holdings' Exchange Rate Effect rose 150.00% to $1,000 in Q3 2022 from the same period last year, while for Sep 2022 it was -$4,000, marking a year-over-year change of. This contributed to the annual value of -$3,000 for FY2021, which is 86.36% up from last year.
  • Latest data reveals that Xeris Biopharma Holdings reported Exchange Rate Effect of -$3,000 as of FY2021, which was up 86.36% from -$22,000 recorded in FY2020.
  • In the past 5 years, Xeris Biopharma Holdings' Exchange Rate Effect registered a high of -$3,000 during FY2021, and its lowest value of -$22,000 during FY2020.
  • For the 2-year period, Xeris Biopharma Holdings' Exchange Rate Effect averaged around -$12,500, with its median value being -$12,500 (2020).
  • Data for Xeris Biopharma Holdings' Exchange Rate Effect shows a peak YoY spiked of 86.36% (in 2021) over the last 5 years.
  • Yearly analysis of 2 years shows Xeris Biopharma Holdings' Exchange Rate Effect stood at -$22,000 in 2020, then skyrocketed by 86.36% to -$3,000 in 2021.